Sharing of Scientific Information

Life Science Law DK invites to a debate on knowledge sharing between companies and healthcare professionals in Denmark, including whether there is a need for clarification or adjustment of the framework for sharing scientific information in Denmark.

AUDIENCE
The event is aimed at lawyers, patent specialists as well as others with an interest in the topic. Participation is free (also for non-members of the association).

BACKGROUND
There is widespread consensus that it is beneficial for patients, healthcare professionals, the healthcare system and companies and Danish society that companies can share scientific information with Danish healthcare professionals. The doctors are further trained and the patients thus receive better treatment. At the same time, doctors are contributing to the research and development of the medicine of the future, which is beneficial patients and Danish society. The opportunities for knowledge sharing between industry and healthcare professionals are partly regulated by Danish legislation partly by the companies ’own ethical guidelines (including ENLI’s Advertising Code). Traditionally, knowledge sharing has taken place in connection with meeting activities, including companies sponsoring physicians' participation in international congresses, where there are typically special interest in publishing new data for already approved products or new products. In recent years, several companies have chosen to move away from sponsoring physicians' participation in international congresses. At the same time, the development of technology and the increasing digitalization are doing so more attractive to use digital solutions for knowledge sharing, including communication, training, meeting activities and the like. Examples from Europe are live streaming from meetings where the speaker located in another country, live streaming from international congresses or subsequent sharing of video recordings (on demand) via a website hosted by a congress organizer, a third party or possibly a company. The question is to what extent the current Danish practice sufficiently takes into account the right balance between scientific knowledge sharing, including sharing information about the future medicines, and the general interest in ensuring that doctors and other healthcare professionals maintain their integrity in relation to the choice of the right treatment for the individual patient. There are examples that activities that according to current practice are not legal in Denmark can implemented in other European countries.

Course certificates corresponding to 3 lessons are issued, which are handed out after the event. If you want to receive one course certificate, please write this in connection with your registration.